These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22371525)

  • 21. Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.
    de la Porte PW; Lok DJ; van Veldhuisen DJ; van Wijngaarden J; Cornel JH; Zuithoff NP; Badings E; Hoes AW
    Heart; 2007 Jul; 93(7):819-25. PubMed ID: 17065182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.
    Kimmelstiel C; Levine D; Perry K; Patel AR; Sadaniantz A; Gorham N; Cunnie M; Duggan L; Cotter L; Shea-Albright P; Poppas A; LaBresh K; Forman D; Brill D; Rand W; Gregory D; Udelson JE; Lorell B; Konstam V; Furlong K; Konstam MA
    Circulation; 2004 Sep; 110(11):1450-5. PubMed ID: 15313938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
    Gheorghiade M; Rossi JS; Cotts W; Shin DD; Hellkamp AS; Piña IL; Fonarow GC; DeMarco T; Pauly DF; Rogers J; DiSalvo TG; Butler J; Hare JM; Francis GS; Stough WG; O'Connor CM
    Arch Intern Med; 2007 Oct; 167(18):1998-2005. PubMed ID: 17923601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
    Cleland JG; Louis AA; Rigby AS; Janssens U; Balk AH;
    J Am Coll Cardiol; 2005 May; 45(10):1654-64. PubMed ID: 15893183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome.
    Karlström P; Alehagen U; Boman K; Dahlström U;
    Eur J Heart Fail; 2011 Oct; 13(10):1096-103. PubMed ID: 21715446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic use, progressive heart failure, and death in patients in the DIG study.
    Domanski M; Tian X; Haigney M; Pitt B
    J Card Fail; 2006 Jun; 12(5):327-32. PubMed ID: 16762792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated home telephone self-monitoring reduces hospitalization in patients with advanced heart failure.
    Kurtz B; Lemercier M; Pouchin SC; Benmokhtar E; Vallet C; Cribier A; Bauer F
    J Telemed Telecare; 2011; 17(6):298-302. PubMed ID: 21844176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
    Blair JE; Khan S; Konstam MA; Swedberg K; Zannad F; Burnett JC; Grinfeld L; Maggioni AP; Udelson JE; Zimmer CA; Ouyang J; Chen CF; Gheorghiade M;
    Eur Heart J; 2009 Jul; 30(13):1666-73. PubMed ID: 19411662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure.
    Andersson C; Weeke P; Pecini R; Kjaergaard J; Hassager C; Køber L; Torp-Pedersen C
    Scand Cardiovasc J; 2010 Feb; 44(1):37-44. PubMed ID: 19878095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
    Marijon E; Trinquart L; Otmani A; Leclercq C; Fauchier L; Chevalier P; Klug D; Defaye P; Lellouche N; Mansourati J; Deharo JC; Sadoul N; Anselme F; Maury P; Davy JM; Extramiana F; Hidden-Lucet F; Probst V; Bordachar P; Mansour H; Chauvin M; Jouven X; Lavergne T; Chatellier G; Le Heuzey JY;
    Am Heart J; 2010 Apr; 159(4):659-664.e1. PubMed ID: 20362726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
    Zile MR; Bourge RC; Bennett TD; Stevenson LW; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Kueffer FJ
    J Card Fail; 2008 Dec; 14(10):816-23. PubMed ID: 19041044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Dietary Sodium Restriction on Heart Failure Outcomes.
    Doukky R; Avery E; Mangla A; Collado FM; Ibrahim Z; Poulin MF; Richardson D; Powell LH
    JACC Heart Fail; 2016 Jan; 4(1):24-35. PubMed ID: 26738949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of telemonitoring and ICT-guided disease management in heart failure: Results from the IN TOUCH study.
    Kraai I; de Vries A; Vermeulen K; van Deursen V; van der Wal M; de Jong R; van Dijk R; Jaarsma T; Hillege H; Lesman I
    Int J Med Inform; 2016 Jan; 85(1):53-60. PubMed ID: 26514079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.